Close search modal
News

Mediwhale wins EU CE MDR approval for retinal AI cardiovascular risk tool

Korea Biomedical Review

Mediwhale said Wednesday that its retinal AI solution, Dr. Noon, has obtained certification under the European Union’s Medical Device Regulation (CE MDR).

Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis
Mediwhale secures ₩20 billion in Series C funding, preparing for IPO